Prof Panaccione believed that biologic therapies are generally underutilised in patients with IBD; they are started too late and prescribed to too few…

Europe has the leading prevalence rates of inflammatory bowel diseases (IBD) in the world. It is estimated that 2.5–3.0 million people on the continent bear the condition,1 and the associated costs are on the rise…

Looking back on the last year, it is easy to be awestruck by the progression of clinical gastroenterology and hepatology research, one of the most notable…

Gastroesophageal reflux disease (GERD) is a common gastrointestinal (GI) disorder worldwide. Proton pump inhibitors (PPI) are the mainstay of treatment…

The treatment armamentarium is expanding for patients with UC and Crohn’s disease (CD). The treatments currently available include anti-inflammatory…

In parallel to the blood vascular system, an extensive network of lymphatic vessels circulates throughout the entire body. The lymphatic system plays…

Colorectal cancer (CRC) is one of the most common malignancies in the developed world and with the ‘westernisation’ of diets, other parts of the world…

Prof Gralnek opened the symposium with a clinical case: a 52-year old woman presented with dizziness and explained that she had had bloody stools…

Successful, cost-effective, and efficient management of disease treatment is the driving factor behind many scientific studies, particularly for diseases…